Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without…
Read on
Deprivation, neglect and abuse during childhood can increase a person’s long-term risk of health problems, a new study warns. “Stress is implicated in nine of…
Read on
With implications for research around postpartum depression and other health issues, scientists have tracked the changes pregnancy brings to the female brain. These changes weren’t…
Read on
Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help…
Read on
Newfangled designs intended to make football helmets more protective have overlooked one key component, a new study suggests. Nearly a third of concussions in pro…
Read on
Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study…
Read on
Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar…
Read on
Florida’s six-week abortion ban caused the state’s abortion rate to drop dramatically, new research shows. Abortions in Florida dropped to an estimated 5,630 in May…
Read on
Fear of a having a low blood sugar crash dissuades many people with type 1 diabetes from getting the exercise they need, a new study…
Read on
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese,…
Read on
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led…
Read on
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.…
Read on
